Skip to main content

Table 2 Meta-analysis of the association between the CCND1 A870G polymorphism and prostate cancer risk

From: Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls

Comparisons

Odds ratio

95% confidence interval

P value

Heterogeneity

Effects model

I 2 (%)

P value

A versus G

1.045

0.947 to 1.153

0.380

49.7

0.037

Random

Asians

1.100

0.891 to 1.358

0.374

48.8

0.142

Caucasians

1.026

0.911 to 1.157

0.669

55.8

0.035

AA versus GG

1.088

0.896 to 1.321

0.393

43.0

0.071

Random

Asians

1.245

0.766 to 2.024

0.376

57.1

0.096

Caucasians

1.043

0.835 to 1.303

0.711

43.1

0.104

GA versus GG

1.044

0.941 to 1.158

0.414

0.0

0.936

Fixed

Asians

0.994

0.785 to 1.258

0.958

0.0

0.577

Caucasians

1.056

0.941 to 1.186

0.350

0.0

0.891

GA + AA versus GG

1.053

0.955 to 1.161

0.303

0.0

0.696

Fixed

Asians

1.046

0.837 to 1.308

0.690

0.0

0.538

Caucasians

1.054

0.945 to 1.176

0.341

0.0

0.520

AA versus GG + GA

1.072

0.881 to 1.306

0.486

59.8

0.008

Random

Asians

1.313

0.793 to 2.174

0.290

72.6

0.026

Caucasians

1.003

0.807 to 1.248

0.976

56.3

0.033